ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill Patients

Completed

• Conditions: Critically Ill

• Registration Number: NCT01126554
• Lead Sponsor: University of Zurich

Brief Summary

Comparison of ICG liver testing with copeptin and SAPS II score as prognostic markers in critically ill patients.

Detailed Description

Comparison of different marker for length of stay in the ICU in critically ill patients.

Study Timeline

• Study First Submitted: 2010-05-17
• Study First Submitted QC: 2010-05-18
• Study First Posted: 2010-05-19
• Study Start: 2010-07
• Primary Completion: 2010-12
• Study Completion: 2011-02
• Status Verified: 2014-04
• Last Update Submitted: 2014-04-28
• Last Update Posted: 2014-04-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• All patients admitted to the ICU

Exclusion Criteria

• Not able to understand German

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
prolonged length of stay in the ICU (pLOS) more than 3 days	3 days	see above

Trial Locations

Locations (1)

Surgical ICU, University Hospital Zurich; 🇨🇭 Zurich, Switzerland